BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

JOURNAL ARTICLE published 1 October 2004 in Cancer Research

Authors: Scott M. Wilhelm | Christopher Carter | LiYa Tang | Dean Wilkie | Angela McNabola | Hong Rong | Charles Chen | Xiaomei Zhang | Patrick Vincent | Mark McHugh | Yichen Cao | Jaleel Shujath | Susan Gawlak | Deepa Eveleigh | Bruce Rowley | Li Liu | Lila Adnane | Mark Lynch | Daniel Auclair | Ian Taylor | Rich Gedrich | Andrei Voznesensky | Bernd Riedl | Leonard E. Post | Gideon Bollag | Pamela A. Trail